Arkansas
Hot Springs; Stepping Stone Clinic
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Little Rock; Arkansas Children's Hospital
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
California
Inglewood; Chrishard Medical Group
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Loma Linda; Loma Linda University
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Los Angeles; Research Center
CAPS (CArdene® IV Pediatric Study) A Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging Study Of Cardene I.V. In Pediatric Subjects With Hypertension
Los Angeles; Neufeld Medical Group, Inc.
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Los Angeles; Impact Clinical Trials
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Palo Alto; Lucile Packard Children's Hospital Stanford
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Colorado
Denver; The Children's Hospital
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Florida
Miami; Research Center
CAPS (CArdene® IV Pediatric Study) A Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging Study Of Cardene I.V. In Pediatric Subjects With Hypertension
Miami; Miami Children's Hospital, Pediatric Nephrology
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Miami; University of Miami/Urgent Care Center
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
St. Petersburg; All Children's Hospital
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Georgia
Atlanta; Children's Healthcare of Atlanta/Cardiac Research Department
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Augusta; Office of Clinical Investigative Services, Medical College of Georgia
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Illinois
Park Ridge; Nephrology and Hypertension Consultants, SC
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Park Ridge; Nephrology and Hypertension Consultants, SC
Open-Label clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Kentucky
Louisville; Kosair Charities Pediatric Clinical Research Unit
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Maryland
Baltimore; University of Maryland Medical System
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Massachusetts
Boston; Children's Hospital
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Michigan
Ann Arbor; University of Michigan Health System/Division of Pediatric Nephrology
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Ann Arbor; University of Michigan Health System
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Mississippi
Jackson; University of Mississippi Medical Center
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Tupelo; Endocrinology Consultants, PLLC
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Missouri
Kansas City; Dynamic Clinical Research, Inc.
An 8-week, multicenter, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of the combination of valsartan/HCTZ/amlodipine compared to valsartan/HCTZ, valsartan/amlodipine, and HCTZ/amlodipine in patients with moderate to severe hypertension
St. Louis; Washington University in St. Louis
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
New Jersey
New Brunswick; University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
New York
Bronx; Ira Greifer Children's Kidney Center
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
New Hyde; Schneider Children's Hospital- Pediatric Nephcology
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
New York; New York Presbyterian Hospital
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
North Carolina
Chapel Hill; University of North Carolina - Chapel Hill
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Charlotte; Carolinas Health Care System/CMC-Myers Park
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Durham; Duke University Medical Center/Pediatric and Adult Congenital Heart Program
Open-Label clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Durham; Duke University Medical Center/Pediatric and Adult Congenital Heart Program
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Raleigh; Rex Healthcare
Rheos ™ Pivotal Trial
Ohio
Cleveland; University Hospitals of Cleveland
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Columbus; Children's Hospital
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Columbus; Pediatric Clinical Trials International
Open-Label clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Columbus; Pediatric Clinical Trials International
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Oklahoma
Tulsa; OU Physicians Tulsa Pediatric Research Clinic
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Oregon
Portland; Oregon Health & Science University
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Portland; Northwest Pediatric Kidney Specialists, LLC
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Portland; Radiant Research - Portland
Hypertension Research Study
Pennsylvania
Philadelphia; Thomas Jefferson University
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
South Carolina
Charleston; Medical University of South Carolina
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Charleston; Medical University of South Carolina/The Children's Heart Center of South Carolina
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Tennessee
Memphis; The Endocrine Clinic
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Memphis; University of Tennessee
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Nashville; Vanderbilt University Medical Center
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Texas
Beaumont; Southeast Texas Cardiology Assoc. II, LLP
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Houston; Texas Children's Hospital
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Houston; University of Texas Medical School at Houston
Open-Label clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Houston,; University of Texas Medical School at Houston
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Virginia
Charlottesville; University of Virginia, Nephrology Clinical Research Center
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Fairfax; Child Cardiology Associates
A 10-week clinical research study designed to evaluate the safety and efficacy of an investigational drug for children with high blood pressure. The drug is approved for use in the adult population.
Washington
Seattle; Cardiology, Children's Hospital Medical Center
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Wisconsin
Milwaukee; Children's Hospital of Wisconsin
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
International
Edmonton, Canada; University of Alberta, Walter Mackenzie Health Sciences Centre
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Vancouver, Canada; British Columbia Children's Hospital
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Budapest, Hungary; Gyorgy Gottsegen National Institute of Cardiology
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Szeged, Hungary; University of Szeged, AOK Department of Pediatrics
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Hyderabad, India; The Institute of Medical Sciences, CARE Hospital
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Kochi, India; Amrita Institute of Medical Sciences & Research Centre, Department of Pediatric Cardiology
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Bologna, Italy; Policlinico Sant'Orsola
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Krakow, Poland; Uniwersytecki Szpital Dzieciecy w Krakowie, Oddzial Kardiologiczny
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Warszawa, Poland; Instytut Pomnik Centrum Zdrowia Dziecka, Klinika Kardiologii
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Zabrze, Poland; Slaskie Centrum Chorob Serca, Oddzial Kliniczny Wrodzonych Wad Serca i Kardiologii Dzieciecej
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Moscow, Russia; Institute of Paediatrics and Paediatric Surgery
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Moscow, Russia; Bakoulev Scientific Center for Cardiovascular Surgery RAMS
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Goteborg, Sweden; Barnhjartcentrum
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
Lund, Sweden; Barn-och Ungdomscentrum
A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
